stockrowDexCom, Inc. (DXCM) vs Glaukos Corporation (GKOS)
- DexCom, Inc. DXCM 79.96 −5.33%
- Glaukos Corporation GKOS 225.73 +2.61%
DexCom, Inc. and Glaukos Corporation are both Medical Devices companies. DexCom, Inc. is the larger, with a market value of $31.5B against $13.0B — 2.4× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; DexCom, Inc. trades at 32.6×. Glaukos Corporation grew revenue faster over the last twelve months: 46.9% against 13.0%. DexCom, Inc. has the higher net margin (19.4% vs −24.6%) and the higher return on invested capital (39.0% vs −24.6%). Across the 20 metrics below, DexCom, Inc. leads on 16 and Glaukos Corporation on 4.
Valuation
Profitability
| Metric | DXCM | GKOS | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.42% | 81.13% | 57.76% |
| Operating margin | 23.98% | (25.52%) | (15.07%) |
| Net margin | 19.41% | (24.60%) | (14.45%) |
| Free cash flow margin | 21.52% | 5.22% | (3.88%) |
| Return on equity | 37.67% | (22.84%) | (10.35%) |
| Return on assets | 14.43% | (17.16%) | (17.26%) |
| Return on invested capital | 39.00% | (24.60%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack